We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
52 hedge funds and large institutions have $212M invested in Corvus Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
120% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 10
0.77% more ownership
Funds ownership: 82.82% → 83.59% (+0.77%)
0% more funds holding
Funds holding: 52 → 52 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
41% less capital invested
Capital invested by funds: $360M → $212M (-$148M)
Holders
52
Holders Change
–
Holders Change %
0%
% of All Funds
1.3%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
22
Reduced
10
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$8.59M |
| 2 |
Jennison Associates
New York
|
+$5.07M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$2.93M |
| 4 |
BlackRock
New York
|
+$2.03M |
| 5 |
JP Morgan Chase
New York
|
+$1.91M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.4M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.81M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$2.79M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$2.53M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.88M |
